Request Legal Help Now - Free

Advertisement
LAWSUITS NEWS & LEGAL INFORMATION

Drugs/Medical Legal News Articles & Interviews

View Lawyer Interviews only

Depo-Provera Lawsuit November 2024 Update 

Depo-Provera Lawsuit November 2024 Update  November 19, 2024. By LAS Staff Writer.

Santa Clara, CA Since its approval, the Depo-Provera contraceptive has been linked to serious health risks--particularly the development of brain tumors like meningiomas; these tumors have allegedly been associated with drospirenone-containing birth control, like Depo-Provera.  

Read [ Depo-Provera Lawsuit November 2024 Update  ]

Valsartan Lawsuit October 2024 Update

Valsartan Lawsuit October 2024 Update November 7, 2024. By LAS Staff Writer.

Santa Clara, CA Every day, doctors prescribe Valsartan--an angiotensin II receptor blocker (ARB)--to help patients manage high blood pressure. This drug, known under brand names like Diovan and Prexxartan, is effective in reducing hypertension by relaxing blood vessels. 

Read [ Valsartan Lawsuit October 2024 Update ]

A Setback for Suboxone Film Plaintiffs: Northern District of Ohio's Dismissal Decision

A Setback for Suboxone Film Plaintiffs: Northern District of Ohio's Dismissal Decision November 6, 2024. By Anne Wallace.
Cleveland, OH On September 10, 2024, the Northern District of Ohio dismissed claims against Indivior PLC and two Reckitt Benckiser entities in Suboxone (Buprenorphine/Naloxone) Film Products Liability Litigation in the multidistrict litigation centralized in the Northern District of Ohio. The court’s decision is a significant setback for individuals who suffered serious Suboxone side effects and dental damage from using the sublingual film form of the drug. They allege that Indivior and other defendants failed to adequately warn about the potential for dental erosion and decay associated with the film's acidic properties. 
Read [ A Setback for Suboxone Film Plaintiffs: Northern District of Ohio's Dismissal Decision ]

Sen. Warren Raises the Alarm over Catalent/Novo Nordisk Merger

Sen. Warren Raises the Alarm over Catalent/Novo Nordisk Merger November 1, 2024. By Anne Wallace.
Washington, DC On October 10, U.S. Senator Elizabeth Warren sent a letter to Federal Trade Commission (FTC) Chair Lina Khan, urging the FTC to closely review a proposed merger between Novo Nordisk and Catalent. Catalent is one of the very few suppliers that provide specialized development and manufacturing services to GLP-1 manufacturers. The letter urges the FTC to block the deal if it could hurt Americans by limiting competition and raising the price of life-saving medicine. Not coincidentally, killing competition might also limit the development of drugs without the dangerous side effects of Ozempic.
Read [ Sen. Warren Raises the Alarm over Catalent/Novo Nordisk Merger ]

Zantac Maker Agrees to $2.2 Billion Settlement

Zantac Maker Agrees to $2.2 Billion Settlement October 24, 2024. By Jane Mundy.
Santa Clara, CA The drug maker GSK agreed a few weeks ago to pay up to $2.2 billion to resolve Zantac lawsuits. The blockbuster heartburn drug, which was sold over-the-counter, was removed from the market in 2020 after the FDA ordered all ranitidine (the generic name) products withdrawn, citing unacceptable levels of the chemical N-nitroso dimethylamine (NDMA), a probable human carcinogen. 
Read [ Zantac Maker Agrees to $2.2 Billion Settlement ]

Ozempic and Addiction: A Potential Game-Changer?

Ozempic and Addiction: A Potential Game-Changer? October 23, 2024. By Anne Wallace.
Washington, DC Ozempic, a semaglutide, is a medication primarily used to treat type 2 diabetes. It works by mimicking the effects of a hormone called glucagon-like peptide-1 (GLP-1), which helps regulate blood sugar levels. However, recent studies have revealed a surprising potential benefit: addiction reduction, specifically with reference to alcohol and opioid abuse.

 
Read [ Ozempic and Addiction: A Potential Game-Changer? ]

Suboxone Tooth Decay MDL – Status Update

Suboxone Tooth Decay MDL – Status Update October 21, 2024. By Anne Wallace.
Cleveland, OH In recent years, Suboxone, a critical medication used to treat opioid addiction, has come under fire for its unintended side effects—specifically, severe tooth decay. While the drug has helped millions overcome opioid dependence, patients across the country have filed dangerous drug lawsuits claiming that Suboxone caused serious dental problems, leading to painful and costly procedures as well as social isolation for some individuals. These claims have been consolidated in an ongoing multidistrict litigation (MDL) in the Northern District of Ohio, where patients are suing the manufacturers of Suboxone for failing to warn about the risk of tooth decay. 
Read [ Suboxone Tooth Decay MDL – Status Update ]

Agreement to Settle nearly 38,000 Bard Hernia Mesh Lawsuits

Agreement to settle nearly 38,000 Bard hernia mesh lawsuits October 18, 2024. By Jane Mundy.
Columbus, OH Becton, Dickinson and Company (BD), the parent company of BARD, has agreed to settle about 38,000 hernia mesh lawsuits. Reports indicate that the total payouts could exceed $1 Billion. The mesh lawsuits, some of which go back almost 20 years, allege that Bard designed defective mesh products, failed to adequately test them, and didn’t properly warn users about potential risks.
Read [ Agreement to Settle nearly 38,000 Bard Hernia Mesh Lawsuits ]

Tips for Maximizing Your Compensation in a Malpractice Case

Tips for Maximizing Your Compensation in a Malpractice Case October 11, 2024. By LAS Staff Writer.
Santa Clara, CA Medical malpractice happens when a healthcare expert, via omission or negligent act, injures or causes harm to patients. If you suffer any harm or are injured because of a healthcare professional’s negligence, you’re entitled to compensation. However, your settlement amount primarily depends on how you handle your medical malpractice lawsuit. Discussed below are four tips for maximizing your compensation in a malpractice case.
Read [ Tips for Maximizing Your Compensation in a Malpractice Case ]

Exactech Knee Lawsuit Trial Update

Exactech Knee Lawsuit Trial Update September 26, 2024. By Jane Mundy.
Santa Clara, CA The first Exactech knee bellwether trials in multi-district litigation are slated for July and September 2025. At least 1,670 Exactech lawsuits are involved, blaming a packaging problem that caused hip, knee, shoulder and ankle implants to degrade and fail long before their time. Some patients required replacement surgery within a few years of receiving the implant.
Read [ Exactech Knee Lawsuit Trial Update ]

Page: 1  2  3  4  5  6  7  8  9  -  10»  -  100»  -  127   Next»

Request Legal Help Now! - Free